Atlas Venture Associates IX’s Surface Oncology, Inc. Common Stock SURF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,945,453
| Closed | -$2.56M | – | 7 |
|
|
2023
Q2 | $2.56M | Hold |
2,945,453
| – | – | 14.02% | 2 |
|
|
2023
Q1 | $2.06M | Hold |
2,945,453
| – | – | 9.68% | 2 |
|
|
2022
Q4 | $2.42M | Hold |
2,945,453
| – | – | 12.02% | 2 |
|
|
2022
Q3 | $3.06M | Hold |
2,945,453
| – | – | 9.08% | 2 |
|
|
2022
Q2 | $4.83M | Hold |
2,945,453
| – | – | 10.98% | 2 |
|
|
2022
Q1 | $8.66M | Hold |
2,945,453
| – | – | 7.96% | 3 |
|
|
2021
Q4 | $14.1M | Hold |
2,945,453
| – | – | 6.15% | 3 |
|
|
2021
Q3 | $22.3M | Hold |
2,945,453
| – | – | 7.41% | 3 |
|
|
2021
Q2 | $22M | Hold |
2,945,453
| – | – | 3.87% | 2 |
|
|
2021
Q1 | $23M | Hold |
2,945,453
| – | – | 3.86% | 3 |
|
|
2020
Q4 | $27.2M | Sell |
2,945,453
-1,700,000
| -37% | -$15.7M | 4.31% | 3 |
|
|
2020
Q3 | $32.1M | Hold |
4,645,453
| – | – | 33.16% | 2 |
|
|
2020
Q2 | $30.5M | Hold |
4,645,453
| – | – | 32.59% | 2 |
|
|
2020
Q1 | $8.69M | Hold |
4,645,453
| – | – | 18.37% | 3 |
|
|
2019
Q4 | $8.73M | Hold |
4,645,453
| – | – | 15.22% | 3 |
|
|
2019
Q3 | $6.6M | Hold |
4,645,453
| – | – | 10.86% | 3 |
|
|
2019
Q2 | $13.1M | Hold |
4,645,453
| – | – | 14.01% | 4 |
|
|
2019
Q1 | $22.2M | Hold |
4,645,453
| – | – | 20.82% | 2 |
|
|
2018
Q4 | $19.7M | Hold |
4,645,453
| – | – | 22.68% | 2 |
|
|
2018
Q3 | $50.8M | Hold |
4,645,453
| – | – | 26.9% | 1 |
|
|
2018
Q2 | $75.8M | Buy |
+4,645,453
| New | +$75.8M | 33.35% | 1 |
|